Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Ashley K. Weber"'
Autor:
Zachary W. Schlei, Kalynn A. Rohde, Mary L. Francois, Mary S. Hayney, Donald S. Hawes, Ashley K. Weber, Ruth M. Benca, John M. Dopp, Krista M. Katers, Marissa M. Brokhof, Richard D. Cornwell, Kelly L. Radford, Nathan J. Menninga
Publikováno v:
Progress in Transplantation. 26:149-156
Context: Complications following lung transplantation are common and significantly reduce quality of life, and increase morbidity and mortality. Increasing evidence suggests sleep disorders are prevalent following lung transplantation, but factors as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56887d166eded31390d3382466b0fd64
https://doi.org/10.1177/1526924816640980
https://doi.org/10.1177/1526924816640980
Autor:
Zachary W. Schlei, Mary S. Hayney, Kalynn A. Rohde, Marissa M. Brokhof, Ruth M. Benca, Mary L. Francois, Krista M. Katers, Kelly L. Radford, Nathan J. Menninga, John M. Dopp, Richard D. Cornwell, Ashley K. Weber, Donald S. Hawes
Publikováno v:
Progress in transplantation (Aliso Viejo, Calif.). 27(2)
Background: Lung transplant recipients are at high risk of developing sleep disorders such as insomnia, but the prevalence and features are currently poorly characterized within this population. Since these disorders are associated with increased mor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::874bf643aa5124ea524802b4c81974aa
https://pubmed.ncbi.nlm.nih.gov/28617161
https://pubmed.ncbi.nlm.nih.gov/28617161
Autor:
Mary S. Hayney, Ashley K. Weber
Publikováno v:
Journal of the American Pharmacists Association : JAPhA. 52(6)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5988748a3f65bcf14606d4e074fea56
https://pubmed.ncbi.nlm.nih.gov/23229973
https://pubmed.ncbi.nlm.nih.gov/23229973
Autor:
Jeremiah J. Stromich, David E. Lewis, Ashley K. Weber, Yousef R. Mirzaei, Michael D. Caldwell
Publikováno v:
Bioorganicmedicinal chemistry letters. 20(6)
New adjuvants of warfarin anticoagulant activity have been developed. These compounds, which are 1,4-methano-1,2,3,4-tetrahydroanthracene-9,10-diol derivatives, act synergistically with warfarin to potentiate its anticoagulant effect. None of the com
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::338823a8084704a691f34a3f4426f399
https://pubmed.ncbi.nlm.nih.gov/20167480
https://pubmed.ncbi.nlm.nih.gov/20167480